Stocks›Healthcare›DFTX

DFTX

Definium Therapeutics, Inc.

NasdaqResearch view

Healthcare · Medicinal Chemicals & Botanical Products

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR

SectorHealthcare

Income—

Sales—

Book/sh—

Cash/sh—

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio—

Current Ratio—

Debt/Eq—

EPS (ttm)—

EPS this Y—

EPS past 3/5Y—

Sales past 3/5Y—

EPS Y/Y TTM—

Sales Y/Y TTM—

Shs Outstand—

ROA—

ROE—

ROIC—

Gross Margin—

Oper. Margin—

Profit Margin—

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

Revenue history unavailable.

Follow the news. Track the move.

DFTX story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

DFTX direct/Earnings

Sep 14

DFTX Stock Jumps Overnight As Investors Brace For Phase 3 Results From LSD-Based Anxiety Drug

DFTX stock jumped overnight as investors positioned ahead of Phase 3 results for an LSD-based anxiety drug. The setup is binary: the trial readout can validate the program or expose the risk embedded in the pre-results move.

Price history unavailable

Yahoo Finance · 1d ago

View both sides →

Follow the news. Track the move.